Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Amezinium metilsulfate [INN:JAN]
RN: 30578-37-1
UNII: 03NR868ICX
InChIKey: ZEASXVYVFFXULL-UHFFFAOYSA-N

Classification Codes

  • Antihypotensive
  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formulas

  • C11-H12-N3-O.C-H3-O4-S
  • C12-H15-N3-O5-S

Molecular Weight

  • 313.332
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Amezinium methyl sulfate
  • Amezinium metilsulfate [INN:JAN]

Synonyms

  • 4-Amino-6-methoxy-1-phenylpyridazinium methyl sulfate
  • 4-Amino-6-methoxy-1-phenylpyridazinium-methylsulfat
  • 4-Amino-6-methoxy-1-phenylpyridazinium-methylsulfat [German]
  • Amezinii metilsulfas
  • Amezinii metilsulfas [INN-Latin]
  • Amezinio metilsulfato
  • Amezinio metilsulfato [Spanish]
  • Amezinium methyl sulfate
  • Amezinium metilsulfate
  • Ameziniummetilsulfat
  • Ameziniummetilsulfat [German]
  • EINECS 250-248-0
  • LU 1631
  • Metilsulfate d'amezinium
  • Metilsulfate d'amezinium [INN-French]
  • Metilsulfato de amezinio
  • Metilsulfato de amezinio [INN-Spanish]
  • Regulton
  • Supratonin
  • UNII-03NR868ICX

Systematic Names

  • 4-Amino-6-methoxy-1-phenylpyridazinium methyl sulfate
  • Amezinium metilsulfate
  • Pyridazinium, 4-amino-6-methoxy-1-phenyl-, methyl sulfate

Registry Numbers

CAS Registry Number

  • 30578-37-1

FDA UNII

  • 03NR868ICX

Related Registry Number

  • 41658-78-0 (Parent)

System Generated Number

  • 0030578371

Molecular Formulas

Molecular Formulas

  • C11-H12-N3-O.C-H3-O4-S
  • C12-H15-N3-O5-S

Molecular Formula Fragments

  • C-H3-O4-S
  • C11-H12-N3-O
  • COMPONENT

Structure Descriptors

InChI

1S/C11H11N3O.CH4O4S/c1-15-11-7-9(12)8-13-14(11)10-5-3-2-4-6-10;1-5-6(2,3)4/h2-8,12H,1H3;1H3,(H,2,3,4)

InChIKey

ZEASXVYVFFXULL-UHFFFAOYSA-N

Smiles

[n+]1(c2ccccc2)c(cc(N)cn1)OC.S(OC)(=O)(=O)[O-]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD50 intravenous 60mg/kg (60mg/kg)   Medicamentos de Actualidad. Vol. 18, Pg. 310, 1982.
dog LD50 oral 100mg/kg (100mg/kg)   Medicamentos de Actualidad. Vol. 18, Pg. 310, 1982.
mouse LD50 intravenous 24100ug/kg (24.1mg/kg)   Drugs in Japan Vol. -, Pg. 72, 1995.
mouse LD50 oral 1330mg/kg (1330mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 16, Pg. 1471, 1988.
mouse LD50 subcutaneous 282mg/kg (282mg/kg)   Drugs in Japan Vol. -, Pg. 72, 1995.
rabbit LD50 intravenous 25mg/kg (25mg/kg)   Medicamentos de Actualidad. Vol. 18, Pg. 310, 1982.
rabbit LD50 oral 800mg/kg (800mg/kg)   Medicamentos de Actualidad. Vol. 18, Pg. 310, 1982.
rat LD50 intravenous 24mg/kg (24mg/kg) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 16, Pg. 1471, 1988.
rat LD50 oral 1330mg/kg (1330mg/kg)   Drugs in Japan Vol. -, Pg. 72, 1995.
rat LD50 subcutaneous 282mg/kg (282mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Yakuri to Chiryo. Pharmacology and Therapeutics. Vol. 16, Pg. 1471, 1988.